“Wild experimentation” against tuberculosis at IHU of Marseille

According to the “Mediapart” information, the Hospital-University Institute, led by Didier Raoult, led to 2017 an irregular trial against tuberculosis, causing several patients of serious complications.

Le Monde with AFP

The Hospital-University Institute of Marseille (Ihu Mediterranean Infection), led by the Controversial Professor Didier Raoult, “continued to issue” treatments against tuberculosis “despite the reservations issued by the French drug authority”, Confirmed, Wednesday, October 27, Public Assistance-Hospitals of Marseille (AP-HM).

On the basis of Article 40 of the Code of Criminal Procedure , the National Agency for the Safety of Drug and Health Products (ANSM) seized the Prosecutor of the Republic, believing “that certain studies conducted by the IHU do not have Respected legislation framing the research involving the human person “, reports Wednesday mediapart , according to whom the ANSM also has” diligent [é] an inspection Within the IHU “.

October 22, Mediapart had revealed that,” since at least 2017 and until March 2021, the IHU “had led Wild experimentation against tuberculosis, causing in several patients, including a minor, serious complications.

According to Mediapart, this experimentation used a combination of four drugs whose joint effectiveness had never been evaluated. An experiment conducted despite the refusal of the National Medicine Safety Agency and Health Products (ANSM), which must give rise to research involving human beings, particularly clinical trials of drugs.

Other investigations

The AP-HM, which led a fast internal investigation to the “potential seriousness of the facts reported”, reported on Wednesday that a “research protocol on this combination of antibiotics had been filed by AP-HM “.

A spokesman clarified the France-Presse Agency that this protocol had been tabled in August 2019, but that it had been withdrawn a month later “considering the reserves issued by the ANSM”. However, “in the absence of an open trial and despite the reserves issued by the ANSM, the IHU Mediterranean continued to issue these treatments,” explained the spokesman for the AP-HM.

The survey conducted by the organization depends on the IHU also confirms that “some” patients treated against tuberculosis with the combination of antibiotics involved were “with renal complications, including at least one d ‘between them required surgery, “wrote the AP-HM.

She explains that she will continue her investigations, in connection with the competent guardianship authorities, including ANSM. “The latest” revelations “are a storm in a glass of water,” Tweeted Professor Raoult, Monday.

Concerning the treatment of tuberculosis:
The infectious and tropical disease cluster will soon communicate … https://t.co/8pw2xw9jgw (@didier raoult)

/Media reports.